If you take the prescription drug Xanax, you might want to consult your doctor before continuing to take it.
According to the U.S. Food and Drug Administration, Viatris, the manufacturer of Xanax, recalled 3-milligram extended-release tablets of Xanax XR — the brand name for the drug alprazolam — that were sold in 60-tablet bottles.
The manufacturer’s recall was initiated March 17.
There have been no reports of illnesses or adverse reactions to date.
The FDA initiated its recall of the pills nationwide on Wednesday, April 15, after they “failed dissolution specifications,” according to the agency.
The FDA’s recall was classified as a Class II recall, which means it is “a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,” according to the FDA.
The affected pills have the lot number 8177156 and an expiration date of 02/28/2027.
The pills were dispensed to patients between Aug. 27, 2024, and May 29, 2025, according to the California State Board of Pharmacy.
If you or a loved one has suffered losses due to these or any Viatris product, you may be entitled to compensation. To learn more, contact the experienced attorneys at Breslin and Breslin today.
